SCHEMBL30753758

SCHEMBL30753758

C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C[SeH])NC(=O)[C@H](C[SeH])NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](C[SeH])C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C[SeH])C(=O)O

nearest known ligand 0.63

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ C5AR1 P21730 2/20 0.63
▸ MC4R P32245 1/20 0.56
▸ NMUR2 Q9GZQ4 4/20 0.56
▸ NMUR1 Q9HB89 4/20 0.56
▸ F2 P00734 2/20 0.54
▸ CALCR P30988 5/20 0.54
▸ TFPI P10646 2/20 0.53
▸ NPY1R P25929 1/20 0.53
▸ NPY2R P49146 1/20 0.53
▸ NPY4R P50391 1/20 0.53
▸ NPY5R Q15761 1/20 0.53
▸ RAMP3 O60896 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30233281 0.94 C5AR1 (0.63) C5AR1MC4RNMUR2NMUR1F2
SCHEMBL30753757 0.94 NMUR2 (0.58) C5AR1MC4RNMUR2NMUR1F2
SCHEMBL30788370 0.93 TFPI (0.59) C5AR1MC4RNMUR2NMUR1F2
SCHEMBL30233814 0.92 C5AR1 (0.63) C5AR1MC4RF2CALCRTFPI
SCHEMBL29843099 0.91 C5AR1 (0.58) C5AR1MC4RNMUR2NMUR1F2
SCHEMBL30753760 0.89 C5AR1 (0.64) C5AR1MC4RNMUR2NMUR1CALCR
SCHEMBL29843005 0.89 C5AR1 (0.58) C5AR1MC4RNMUR2NMUR1F2
SCHEMBL29638059 0.89 MC4R (0.61) C5AR1MC4RNMUR2NMUR1F2
SCHEMBL30233422 0.89 C5AR1 (0.58) C5AR1NMUR2NMUR1F2CALCR
SCHEMBL30788367 0.89 F2 (0.56) C5AR1NMUR2NMUR1F2TFPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240041740-A1 SKIN PEEL COMPOSITIONS GLO PHARMA INC (US) 2024-02-08 — — US disclosed
Send feedback